Doctors review records to see how asthma drug performs in real life
NCT ID NCT06455462
Summary
This study looked back at the medical records of 352 UK patients with severe asthma who were treated with the biologic drug tezepelumab. The goal was to understand the types of patients who receive this treatment and how it affects their asthma attacks, symptoms, and quality of life in real-world settings, not a controlled trial. Researchers collected data from before and after patients started the drug to measure its real-world impact.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Birmingham, United Kingdom
-
Research Site
Liverpool, United Kingdom
-
Research Site
London, United Kingdom
-
Research Site
Newcastle, United Kingdom
-
Research Site
Plymouth, United Kingdom
-
Research Site
Southampton, United Kingdom
Conditions
Explore the condition pages connected to this study.